Detection of the ADGRG6 hotspot mutations in urine for bladder cancer early screening by ARMS‐qPCR

BACKGROUND: In bladder cancer, recurrent ADGRG6 enhancer hotspot mutations (chr. 6: 142,706,206 G>A, chr. 6:142,706,209 C>T) were reported at a high mutation rate of approximately 50%. Thus, ADGRG6 enhancer mutation status might be a candidate for diagnostic biomarker. METHODS: To improve test...

Descripción completa

Detalles Bibliográficos
Autores principales: Tan, Dan, Jiang, Wenqi, Hu, Rixin, Li, Zhuoran, Ou, Tong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2023
Materias:
RESEARCH ARTICLES
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10242345/
https://www.ncbi.nlm.nih.gov/pubmed/37081791
http://dx.doi.org/10.1002/cam4.5879

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10242345/
https://www.ncbi.nlm.nih.gov/pubmed/37081791
http://dx.doi.org/10.1002/cam4.5879

Ejemplares similares